This company has been marked as potentially delisted and may not be actively trading. Elicio Therapeutics (ELTX) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Elicio Therapeutics (NASDAQ:ELTX)CurrentInstitutional OwnershipPercentage35.03%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$1.06MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$152.75K Get ELTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Elicio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELTX Institutional Buying and Selling by Quarter Elicio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025Jane Street Group LLC14,993$92K0.0%N/A0.139% 5/15/2025Royal Bank of Canada36,537$225K0.0%N/A0.339% 5/9/2025CM Management LLC55,000$339K0.3%+37.5%0.510% 4/28/2025Moody Lynn & Lieberson LLC10,000$62K0.0%N/A0.093% 2/7/2025CM Management LLC40,000$204K0.2%-20.0%0.371% 8/15/2024Armistice Capital LLC100,000$411K0.0%N/A0.978% 8/9/2024Warberg Asset Management LLC11,801$49K0.0%N/A0.115% 8/2/2024CM Management LLC50,000$206K0.2%-33.3%0.489% 5/14/2024CM Management LLC75,000$570K0.5%+50.0%0.733% 8/4/2023CM Management LLC65,000$618K0.6%N/A2.159% (Data available from 1/1/2016 forward) ELTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Elicio Therapeutics shares: Armistice Capital LLC ($411K), CM Management LLC ($339K), Royal Bank of Canada ($225K), Jane Street Group LLC ($92K), and Moody Lynn & Lieberson LLC ($62K), Warberg Asset Management LLC ($49K).Learn more on Elicio Therapeutics' institutional investors. What percentage of Elicio Therapeutics' stock is owned by institutional investors? 35.03% of Elicio Therapeutics' stock is owned by institutional investors. Learn more on ELTX's institutional investor holdings. Which institutional investors have been buying Elicio Therapeutics' stock? The following institutional investors have purchased Elicio Therapeutics' stock in the last 24 months: CM Management LLC ($105K), Armistice Capital LLC ($100K), Royal Bank of Canada ($36.54K), Jane Street Group LLC ($14.99K), Warberg Asset Management LLC ($11.80K), and Moody Lynn & Lieberson LLC ($10K). How much institutional buying is happening at Elicio Therapeutics? Institutional investors have bought a total of 188,331 shares in the last 24 months. This purchase volume represents approximately $1.06M in transactions. Which of Elicio Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Elicio Therapeutics stock in the last 24 months: CM Management LLC ($35K). How much institutional selling is happening at Elicio Therapeutics? Institutional investors have sold a total of 35,000 shares in the last 24 months. This volume of shares sold represents approximately $152.75K in transactions. Related Companies PRME Institutional Ownership MAZE Institutional Ownership OPT Institutional Ownership AXGN Institutional Ownership KIDS Institutional Ownership TYRA Institutional Ownership MLAB Institutional Ownership TLRY Institutional Ownership CELC Institutional Ownership RXST Institutional Ownership This page (NASDAQ:ELTX) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elicio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elicio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
